Jump to content

Catherine Day (biochemist)

Add links
From Wikipedia, the free encyclopedia

Catherine Day
Day in 2012
Alma materMassey University
Scientific career
Thesis

Catherine Louise Day is a New Zealand biochemist. She is currently a professor and was the head of the biochemistry department at the University of Otago.[1]

Career

[edit]

After a BSc at Massey University, Day completed a PhD entitled Expression and characterisation of the n-terminal half of human lactoferrin in 1993,[2] also at Massey, before moving to the University of Otago where she rose to professor and head of department.[1]

She has received funding from the Health Research Council of New Zealand[3][4] and Genesis Oncology Trust[5] and is an associate editor for biochemistry and biophysics of the Royal Society's Open Science Journal.[6]

Awards

[edit]

Day won the Otago School of Medical Sciences' top award for 2010.[4]

Selected works

[edit]
  • Chen, Lin, Simon N. Willis, Andrew Wei, Brian J. Smith, Jamie I. Fletcher, Mark G. Hinds, Peter M. Colman, Catherine L. Day, Jerry M. Adams, and David CS Huang. "Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function." Molecular Cell 17, no. 3 (2005): 393–403.[7]
  • Van Delft, Mark F., Andrew H. Wei, Kylie D. Mason, Cassandra J. Vandenberg, Lin Chen, Peter E. Czabotar, Simon N. Willis et al. "The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized." Cancer cell 10, no. 5 (2006): 389–399.[8]
  • Verhagen, Anne M., John Silke, Paul G. Ekert, Miha Pakusch, Hitto Kaufmann, Lisa M. Connolly, Catherine L. Day et al. "HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins." Journal of Biological Chemistry 277, no. 1 (2002): 445–454.[9]
  • Czabotar, Peter E., Erinna F. Lee, Mark F. van Delft, Catherine L. Day, Brian J. Smith, David CS Huang, W. Douglas Fairlie, Mark G. Hinds, and Peter M. Colman. "Structural insights into the degradation of Mcl-1 induced by BH3 domains." Proceedings of the National Academy of Sciences 104, no. 15 (2007): 6217–6222.[10]

References

[edit]
  1. ^ a b "Profile, Department of Biochemistry, University of Otago, New Zealand". Otago.ac.nz. Retrieved 16 December 2017.
  2. ^ Day, Catherine (1993). Expression and characterisation of the n-terminal half of human lactoferrin (Doctoral thesis). Massey Research Online, Massey University. hdl:10179/4125.
  3. ^ "Professor Catherine Day | Health Research Council". Hrc.govt.nz. Retrieved 16 December 2017.
  4. ^ a b Rudd, Allison (4 February 2011). "School of medical sciences names researcher of year". Otago Daily Times Online News. Retrieved 10 August 2024.
  5. ^ "Monday 4 December 2017, Otago researchers gain new insights into inflammatory signalling mechanisms implicated in cancer, News and events, Department of Biochemistry, University of Otago, New Zealand". Otago.ac.nz. 4 December 2017. Retrieved 16 December 2017.
  6. ^ "Biochemistry and Biophysics | Open Science". Rsos.royalsocietypublishing.org. Archived from the original on 16 December 2017. Retrieved 16 December 2017.
  7. ^ Chen, Lin; Willis, Simon N.; Wei, Andrew; Smith, Brian J.; Fletcher, Jamie I.; Hinds, Mark G.; Colman, Peter M.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S. (4 February 2005). "Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function". Molecular Cell. 17 (3): 393–403. doi:10.1016/j.molcel.2004.12.030. ISSN 1097-2765. PMID 15694340.
  8. ^ van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M. (November 2006). "The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized". Cancer Cell. 10 (5): 389–399. doi:10.1016/j.ccr.2006.08.027. ISSN 1535-6108. PMC 2953559. PMID 17097561.
  9. ^ Verhagen, Anne M.; Silke, John; Ekert, Paul G.; Pakusch, Miha; Kaufmann, Hitto; Connolly, Lisa M.; Day, Catherine L.; Tikoo, Anjali; Burke, Richard; Wrobel, Carolyn; Moritz, Robert L. (4 January 2002). "HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins". The Journal of Biological Chemistry. 277 (1): 445–454. doi:10.1074/jbc.M109891200. ISSN 0021-9258. PMID 11604410.
  10. ^ Czabotar, Peter E.; Lee, Erinna F.; van Delft, Mark F.; Day, Catherine L.; Smith, Brian J.; Huang, David C. S.; Fairlie, W. Douglas; Hinds, Mark G.; Colman, Peter M. (10 April 2007). "Structural insights into the degradation of Mcl-1 induced by BH3 domains". Proceedings of the National Academy of Sciences of the United States of America. 104 (15): 6217–6222. Bibcode:2007PNAS..104.6217C. doi:10.1073/pnas.0701297104. ISSN 0027-8424. PMC 1851040. PMID 17389404.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Catherine_Day_(biochemist)&oldid=1239580708"